![]() |
Volumn 30, Issue 5, 1998, Pages 2171-2173
|
Tacrolimus (FK 506) in kidney transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOSPORIN A;
LYMPHOCYTE ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
TACROLIMUS;
THYMOCYTE ANTIBODY;
TRANSFORMING GROWTH FACTOR BETA;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG EFFICACY;
DRUG MECHANISM;
GINGIVA HYPERPLASIA;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEMOLYTIC UREMIC SYNDROME;
HUMAN;
HYPERLIPIDEMIA;
HYPERTENSION;
HYPERTRICHOSIS;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY TRANSPLANTATION;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
SURVIVAL;
TREMOR;
BLOOD PRESSURE;
CYCLOSPORINE;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
TACROLIMUS;
TREMOR;
|
EID: 0031657389
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)00578-8 Document Type: Conference Paper |
Times cited : (13)
|
References (20)
|